ctdna as a diagnostic, prognostic, and predictive biomarker for lung cancer
Published 3 years ago • 275 plays • Length 3:44Download video MP4
Download video MP3
Similar videos
-
3:44
evaluating the use of ctdna as a biomarker in lung cancer
-
1:02
galaxy: ctdna as a prognostic biomarker in resected colorectal cancer
-
3:30
ctdna as an mrd biomarker for nsclc
-
1:09
ctdna mrd as a biomarker for solid tumors
-
3:32
the role of ctdna in lung cancer screening
-
2:18
empower-lung 1: ctdna as a biomarker for treatment responses in nsclc
-
1:21
nadim: baseline ctdna as a prognostic factor for pfs
-
3:00
liquid biopsy: future directions for ctdna in nsclc
-
2:12
ctdna measurement via liquid biopsy: improving cancer detection and diagnosis
-
3:43
evolving applications of ctdna in lung cancer: mrd, early detection, and molecular profiling
-
6:22
utilising ctdna in oncology
-
0:42
what future does ctdna have as a biomarker in breast cancer?
-
0:29
innovative ctdna-based liquid biopsy techniques for cancer diagnosis
-
0:45
the emerging role of ctdna in cancer diagnostics
-
2:23
ctdna signatures to detect lung cancer
-
8:45
ctdna as a novel biomarker for mrd in crc
-
6:55
the prognostic value of ctdna in nsclc treated with neoadjuvant chemoimmunotherapy
-
0:55
prognostic biomarkers of immunotherapy efficacy in breast cancer
-
3:06
the application of liquid biopsy ctdna analysis in nsclc